Human Genome Epidemiology Literature Finder
|
Records 1 - 9 (of 9 Records) |
| Query Trace: Endometrial Neoplasms and FBXW7[original query] |
|---|
| High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma. Gynecologic oncology 2013 Feb 128 (2): 327-34. Garcia-Dios Diego A, Lambrechts Diether, Coenegrachts Lieve, Vandenput Ingrid, Capoen An, Webb Penelope M, Ferguson Kaltin, , Akslen Lars A, Claes Bart, Vergote Ignace, Moerman Philippe, Van Robays Johan, Marcickiewicz Janusz, Salvesen Helga B, Spurdle Amanda B, Amant Frédér |
| Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Proceedings of the National Academy of Sciences of the United States of America 2013 Jan . Zhao S, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD |
| Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 Jun 28 (6): 836-44. Stelloo Ellen, Bosse Tjalling, Nout Remi A, MacKay Helen J, Church David N, Nijman Hans W, Leary Alexandra, Edmondson Richard J, Powell Melanie E, Crosbie Emma J, Kitchener Henry C, Mileshkin Linda, Pollock Pamela M, Smit Vincent T, Creutzberg Carien |
| Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study. Gynecologic oncology 2016 Apr 141 (1): 43-8. Myers Andrea P, Filiaci Virginia L, Zhang Yuping, Pearl Michael, Behbakht Kian, Makker Vicky, Hanjani Parviz, Zweizig Susan, Burke James J, Downey Gordon, Leslie Kimberly K, Van Hummelen Paul, Birrer Michael J, Fleming Gini |
| Phosphatidylinositol 3-Kinase ?-Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 2 36 (13): 1291-1299. Juric Dejan, Rodon Jordi, Tabernero Josep, Janku Filip, Burris Howard A, Schellens Jan H M, Middleton Mark R, Berlin Jordan, Schuler Martin, Gil-Martin Marta, Rugo Hope S, Seggewiss-Bernhardt Ruth, Huang Alan, Bootle Douglas, Demanse David, Blumenstein Lars, Coughlin Christina, Quadt Cornelia, Baselga Jo |
| Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study. European journal of cancer care 2019 8 28 (6): e13137. Lupini Laura, Scutiero Gennaro, Iannone Piergiorgio, Martinello Ruby, Bassi Cristian, Ravaioli Noemi, Soave Ilaria, Bonaccorsi Gloria, Lanza Giovanni, Gafà Roberta, Loizzi Vera, Negrini Massimo, Greco Pantal |
| PP2A and E3 ubiquitin ligase deficiencies: Seminal biological drivers in endometrial cancer. Gynecologic oncology 2021 Apr . Gonzalez-Bosquet Jesus, Bakkum-Gamez Jamie N, Weaver Amy L, McGree Michaela E, Dowdy Sean C, Famuyide Abimbola O, Kipp Benjamin R, Halling Kevin C, Couch Fergus J, Podratz Karl |
| Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer. Journal of translational medicine 2021 Feb 19 (1): 51. Feng Weiwei, Jia Nan, Jiao Haining, Chen Jun, Chen Yan, Zhang Yueru, Zhu Menghan, Zhu Chongying, Shen Lifei, Long Wenqi |
| Druggable genetic targets in endometrial cancer. Cancer treatment and research communications 2021 12 30 100502. Lehrer Steven, Rheinstein Peter |
- Page last reviewed:Feb 1, 2024
- Content source: